Is this trial misreported? Truth seeking in the burgeoning age of trial transparency

BMJ (Online)

Volumn 355, Issue , 2016, Pages

  Doshi, Peter ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE; PLACEBO;

ACUPUNCTURE; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HEPATITIS C; HUMAN; NECK PAIN; PRIORITY JOURNAL; PUBLICATION; REGISTRATION; REPORTING BIAS; SCIENTIFIC MISCONDUCT; SELECTIVE REPORTING; ACCESS TO INFORMATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTER; STANDARDS; TREATMENT OUTCOME;

ACCESS TO INFORMATION; CLINICAL PROTOCOLS; HUMANS; PERIODICALS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; TREATMENT OUTCOME;

EID: 84994043990     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.i5543     Document Type: Article

References (43)

1. GSK knew Seroxat wasn't 'effective' on children. BBC News 2004 Feb 3.http://news.bbc.co.uk/2/hi/programmes/panorama/3454873.stm
2. FDA. Clinical review: paroxetine. 2002. www.fda.gov/downloads/Drugs/ DevelopmentApprovalProcess/DevelopmentResources/UCM371260.pdf
3. Keller MB, Ryan ND, Strober M, et al. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 2001;40:762-72. doi:10.1097/00004583-200107000-00010pmid:11437014.
4. Memo to sales representatives. 2001. http://www.healthyskepticism.org/documents/ documents/20010816Hawkinstoreps.pdf
5. GSK. Paroxetine - paediatric and adolescent patients.http://www.gsk.com/en-gb/media/ resource-centre/paroxetine/paroxetine-paediatric-and-adolescent-patients/
6. Jureidini J, McHenry L, Mansfield P. Clinical trials and drug promotion: selective reporting of study 329. Int J Risk Saf Med 2008;20:73-81.
7. Le Noury J, Nardo JM, Healy D, et al. Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence. BMJ 2015;351:h4320. doi:10.1136/bmj.h4320pmid:26376805.
8. Chan A-W, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004;291:2457-65. doi:10.1001/jama.291.20.2457. pmid:15161896.
9. Rennie D. Trial registration: a great idea switches from ignored to irresistible. JAMA 2004;292:1359-62. doi:10.1001/jama.292.11.1359pmid:15355937.
10. DeAngelis CD, Drazen JM, Frizelle FA, et al. International Committee of Medical Journal Editors. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. JAMA 2004;292:1363-4. doi:10.1001/jama.292.11.1363. pmid:15355936.
11. Zarin DA, Tse T, Sheehan J. The proposed rule for U.S. clinical trial registration and results submission. N Engl J Med 2015;372:174-80. doi:10.1056/NEJMsr1414226. pmid: 25539444.
12. Dickersin K, Rennie D. The evolution of trial registries and their use to assess the clinical trial enterprise. JAMA 2012;307:1861-4. doi:10.1001/jama.2012.4230. pmid:22550202.
13. COMPare. Tracking switched outcomes in clinical trials. 2016. www.COMPare-trials.org
14. COMPare. Post-hoc "pre-specification" and undeclared deferral of results: a broken record in the making. 29 Jan 2016.http://compare-trials.org/blog/post-hoc-pre-specification-andundeclared- separation-of-results-a-broken-record-in-the-making/
15. MacPherson H, Tilbrook H, Richmond S, et al. Alexander technique lessons or acupuncture sessions for persons with chronic neck pain: a randomized trial. Ann Intern Med 2015;163:653-62. doi:10.7326/M15-0667pmid:26524571.
16. COMPare. Trial 25 assessment. https://docs.google.com/spreadsheets/d/ 1qVmaNwxclrTtZzUh2YaecFj7bOIAIndvRSoRkHyQMBQ/edit?pref=2&pli=1#gid=0 &
17. COMPare. Trial 25 letter. https://docs.google.com/document/d/1M- KNDBeSh4WVvWyz4nobpon4-LYGNNOlG-dXChChUTo/edit?pref=2&pli=1
18. MacPherson H, Tilbrook HE, Richmond SJ, et al. Alexander technique lessons, acupuncture sessions or usual care for patients with chronic neck pain (ATLAS): study protocol for a randomised controlled trial. Trials 2013;14:209. doi:10.1186/1745-6215-14- 209pmid:23841901.
19. Slade E, Dryden H, Goldacare B. Electronic response to: MacPherson et al Ann Intern Med 2015 http://annals.org/article.aspx?articleid=2467961.
20. COMPare. How did NEJM respond when we tried to correct 20 misreported trials? 25 Feb 2016. http://compare-trials.org/blog/how-did-nejm-respond-when-we-tried-to-correct- 20-misreported-trials/
21. NEJM replies. https://www.propublica.org/documents/item/2783316-NEJM-replies.html
22. COMPare reply. https://www.propublica.org/documents/item/2783318-Compare-Reply.html
23. Feld JJ, Jacobson IM, Hézode C, et al. ASTRAL-1 Investigators. Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection. N Engl J Med 2015;373:2599-607. doi:10. 1056/NEJMoa1512610pmid:26571066.
24. COMPare. Trial 49 letter. https://docs.google.com/document/d/ 1YvUqNW7sXhaWFTd4iQhrD6dVbfc3NCHZcKVowbXwZUM/edit
25. Drazen JM, Zarin DA. Salvation by registration. N Engl J Med 2007;356:184-5. doi:10. 1056/NEJMe068291pmid:17215537.
26. DeAngelis CD, Drazen JM, Frizelle FA, et al. International Committee of Medical Journal Editors. Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. JAMA 2005;293:2927-9. doi:10.1001/jama.293.23.jed50037pmid:15911838.
27. McCook A. In major shift, medical journal to publish protocols along with clinical trials. Retraction Watch 13 May 2016. http://retractionwatch.com/2016/05/13/in-major-shiftannals- to-publish-protocols-along-with-clinical-trials/
28. Drysdale HM. Discrepancies between pre-specified and reported outcomes in Gilbody et al. Electronic response to Gilbody et al Computerised cognitive behaviour therapy (cCBT) as treatment for depression in primary care (REEACT trial): large scale pragmatic randomised controlled trial BMJ 2015. http://www.bmj.com/content/351/bmj.h5627/rr-12 &
29. Drysdale HM, Goldacre B. Response to the authors: Outcomes consist of time-points and methods of measurement, as stated in CONSORT. Electronic response to van der Aa et al Stepped care for depression and anxiety in visually impaired older adults: multicentre randomised controlled trial. BMJ 2015.http://www.bmj.com/content/351/bmj.h6127/rr-1
30. Computerised cognitive behaviour therapy (cCBT) as treatment for depression in primary care (REEACT trial): large scale pragmatic randomised controlled trial. BMJ 2016;352:i195. http://www.bmj.com/content/352/bmj.i195.pmid:26759375.
31. Drysdale H. REEACT in the BMJ: Good science in action. 20 Jan 2016. http://comparetrials.org/blog/reeact-in-the-bmj-good-science-in-action/
32. Goldacre B. JAMA reject correction letters on all trials they have misreported24 Mar 2016.http://compare-trials.org/blog/jama-reject-all-correction-letters/
33. Goldacre B. The Lancet and COMPare: why journals should address outcome switching themselves. 29 Apr 2016. http://compare-trials.org/blog/the-lancet-and-compare-whyjournals- should-address-outcome-switching-themselves/
34. COMPare. Trial 039 assessment. https://docs.google.com/spreadsheets/d/ 1CBHSYsvqK5C1YztzA9L6i0o5KkbRG2zjoTpHIMz87uA/edit#gid=0
35. COMPare. Letter to NEJM 2 Dec 2015. https://docs.google.com/document/d/ 1eDeSFToRbaaz7y1WYFNUpHkpRO6rZPh6aiCXaCXZ-Ys/edit
36. View of NCT01751906 on 2013-01-08. https://clinicaltrials.gov/archive/NCT01751906/ 2013-01-08
37. Protocol for: Ellis SG, Kereiakes DJ, Metzger DC, et al. Everolimus-eluting bioresorbable scaffolds for coronary artery disease. N Engl J Med 2015.http://www.nejm.org/doi/suppl/ 10.1056/NEJMoa1509038/suppl-file/nejmoa1509038-protocol.pdf
38. Centre for Evidence Based Medicine Outcome Monitoring Project protocol. (last amended 18 May 2016). http://compare-trials.org/wp-content/uploads/2016/01/COMPare-Protocol- 18.5.2016.pdf
39. Zarin DA, Tse T. Sharing individual participant data (IPD) within the context of the trial reporting system (TRS). PLoS Med 2016;13:e1001946. doi:10.1371/journal.pmed.1001946.pmid:26784335.
40. Hartung DM, Zarin DA, Guise JM, McDonagh M, Paynter R, Helfand M. Reporting discrepancies between the ClinicalTrials.gov results database and peer-reviewed publications. Ann Intern Med 2014;160:477-83. doi:10.7326/M13-0480pmid:24687070.
41. Schwartz LM, Woloshin S, Zheng E, Tse T, Zarin DA. ClinicalTrials.gov and Drugs@FDA: A comparison of results reporting for new drug approval trials. Ann Intern Med 2016;165:421-30. doi:10.7326/M15-2658pmid:27294570.
42. Zarin DA, Tse T. Trust but verify: trial registration and determining fidelity to the protocol. Ann Intern Med 2013;159:65-7. doi:10.7326/0003-4819-159-1-201307020-00011pmid: 23817705.
43. Goldacre B. Where does Annals of Internal Medicine stand on outcome switching? A detailed response. 20 Jan 2016. http://compare-trials.org/blog/where-does-annals-ofinternal- medicine-stand-on-outcome-switching-a-detailed-response/#more-232